Neuro-imaging business Compumedics (ASX: CMP) has successfully overseen the installation of its advanced technology at the renowned Tianjin Normal University, firmly embedding the Company within China's rapidly-developing neuroscience industry.
The Company's Orion LifeSpan technology is a cutting-edge magnetoencephalography (MEG) system. MEG technologies are non-invasive and use highly sensitive equipment to measure magnetic fields produced by the brain's electrical activity.
In a world-first of its kind, the Orion LifeSpan system deployed in Tianjin uses a unique dual-helmet design to conduct neuroimaging of two subjects at the same time to study how they interact.
The installation is a material step forward for Compumedics but is also important as a demonstration of the company’s commitment to the many commercial opportunities within the emerging MEG market.
Compumedics has previously booked the $4.7 million sale in its full year FY2024 results, but will receive a final payment as the part of the completion and sign-off. The company is currently building the MEG systems for two additional orders accounting for $9.3 million in sales value, for delivery during 2025.
Tianjin Normal University, founded in 1958, has rich resources and excellent facilities with two faculties and twenty separate colleges, 2,531 faculty and 32,550 full-time students studying a complete range of disciplines. The university's Brain Function Imaging Centre was established in 2019 and includes MRI, fNIRS, EEG/ERP, TMS and TCDS laboratories, alongside the Orion LifeSpan MEG.
TJNU’s acceptance of the MEG system was the result of a thorough technical review of all relevant performance specifications. Exciting research work has already begun using the Orion LifeSpan MEG, with system time even now almost completely booked.
“We are honoured and delighted to announce this critical milestone in the evolution and advancement of our MEG technology and the commercial traction of the business model,” Gordon Haid, Compumedics Global Neuro-Imaging Business Director, said.
“We view China as an important and large source of opportunities for MEG scientific research which is currently underutilised in the country. The acceptance of TJNU is another significant step forward on our shared mission to advance understanding of the human brain. TJNU highlighted hyperscanning capability, optimised simultaneous MEG/EEG and the dual-helmet configuration to study brain development from child to adult as significant benefits of the Orion LifeSpan, all of which are now delivered and accepted by the customer to their satisfaction.”
